Buchumschlag

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jannis Kountouras, Elisabeth Vardaka, Christos Zavos, Dimitrios Chatzopoulos, Maria Tzitiridou‐Chatzopoulou, Dimitrios Tzilves, Georgia Zournatzidou, Foteini Kyrailidou, Maria C. Mouratidou
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH
von: Jannis Kountouras, et al.
Veröffentlicht: (2024)

Letter: H. pylori Infection May Constitute a Risk Factor for Reflux Disease and Colonic Neoplasia
von: Jannis Kountouras, et al.
Veröffentlicht: (2025)

Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease
von: Jannis Kountouras, et al.
Veröffentlicht: (2024)

Helicobacter pylori and Porphyromonas gingivalis Infections as Potential Risk Predictors for Gastric Cancer and Two Types of Esophageal Cancer
von: Jannis Kountouras, et al.
Veröffentlicht: (2026)

Helicobacter pylori and metabolic syndrome‐related adipokines in nonalcoholic fatty liver disease pathophysiology
von: J Kountouras, et al.
Veröffentlicht: (2024)

Letter: Potential impact ofHelicobacter pyloriinfection on oesophageal disorders in chronic liver disease—Authors' reply
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2024)

Letter: Combination Therapies With Vitamin E for Metabolic Dysfunction‐Associated Steatotic Liver Disease
von: Stergios A. Polyzos, et al.
Veröffentlicht: (2024)

Letter: Helicobacter pylori and Eosinophilic Oesophagitis—Lost in Definition?
von: Fernanda Cristofori, et al.
Veröffentlicht: (2025)

Letter: Helicobacter pylori and Eosinophilic Oesophagitis—Lost in Definition? Authors' Reply
von: Irene Spinelli, et al.
Veröffentlicht: (2025)

Letter: Meta‐Analysis Critique: Refining the Association Between Helicobacter pylori and Eosinophilic Oesophagitis
von: Haleema Rahman
Veröffentlicht: (2025)

Helicobacter pylori Eradication Regimens With Adjuvant Probiotics Efficacy in the Treatment of Hepatic Encephalopathy
von: Jannis Kountouras, et al.
Veröffentlicht: (2025)

Letter: Zinc and selenium—Potential biomarkers for chronic liver disease?
von: Zhuo Li, et al.
Veröffentlicht: (2024)

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
von: Jian Wang, et al.
Veröffentlicht: (2024)

Letter: Disappearing Microbe, Emerging Disease? Nuancing the Protective Effects of Helicobacter pylori Against Eosinophilic Oesophagitis
von: Enzo Emanuele, et al.
Veröffentlicht: (2025)

Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH—Authors’ reply
von: S. K. Bansal, et al.
Veröffentlicht: (2024)

Letter: Disappearing Microbe, Emerging Disease? Nuancing the Protective Effects of Helicobacter pylori Against Eosinophilic Oesophagitis. Authors' Reply
von: Irene Spinelli, et al.
Veröffentlicht: (2025)

Helicobacter pylori and Metabolic Syndrome‐Related Mast Cells May Be Potential Risk Factors for the Increased Prevalence of Barrett's Esophagus
von: Jannis Kountouras, et al.
Veröffentlicht: (2025)

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
von: Lisa Sandmann, et al.
Veröffentlicht: (2024)

Letter: Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in chronic hepatitis B virus infection
von: Jianrong Li, et al.
Veröffentlicht: (2024)

Review article: Oesophageal disorders in chronic liver disease
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2024)

Letter: Reflections on the significance of myokines in alcohol‐associated liver disease
von: Yaomin Wang, et al.
Veröffentlicht: (2024)

Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection—Questions Focused on Clinical Practice
von: Javier P. Gisbert, et al.
Veröffentlicht: (2026)

Helicobacter pylori‐Associated Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut Barrier Damage in Liver Cirrhosis
von: Jannis Kountouras, et al.
Veröffentlicht: (2025)

Letter: Clarifying the Synergistic Mechanisms of Mediterranean Diet and Time‐Restricted Feeding in MASLD Management—Authors' Reply
von: Sofia Tsitsou, et al.
Veröffentlicht: (2025)

Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases
von: Ivan Arcari, et al.
Veröffentlicht: (2024)

Racial and ethnic disparities in post‐liver transplant outcomes for patients with acute‐on‐chronic liver failure: An analysis of the UNOS database
von: David Uihwan Lee, et al.
Veröffentlicht: (2024)

Editorial: Reading the cholate – A new gateway to portal hypertension and oesophageal varices
von: Iulia Minciuna, et al.
Veröffentlicht: (2024)

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease
von: Nina Dominik, et al.
Veröffentlicht: (2024)

Letter: Association between chronic kidney disease, hepatitis B and antiviral treatments
von: Chen‐Pi Li, et al.
Veröffentlicht: (2024)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B
von: Jian Wang, et al.
Veröffentlicht: (2024)

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply
von: Stuart McPherson, et al.
Veröffentlicht: (2024)

Editorial: Eosinophilic oesophagitis coming of age—Increasing frequency and wider age range—Authors' reply
von: Akshatha Kiran, et al.
Veröffentlicht: (2024)

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms–still a long way to go…
von: Sabine Roman, et al.
Veröffentlicht: (2024)

Editorial: Reading the cholate—A new gateway to portal hypertension and oesophageal varices: Authors' reply
von: Tarek Hassanein, et al.
Veröffentlicht: (2024)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B—Author's reply
von: Hyeyeon Hong, et al.
Veröffentlicht: (2024)

Letter: Using non‐invasive fibrosis tests and emerging diagnostics to enhance the accuracy of liver fibrosis staging in MASLD patients
von: Wenjun Meng, et al.
Veröffentlicht: (2024)

Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study
von: Francesco Calabrese, et al.
Veröffentlicht: (2024)

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply'
von: Francesco Calabrese, et al.
Veröffentlicht: (2024)

Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices
von: Tarek Hassanein, et al.
Veröffentlicht: (2024)

Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis B
von: Jing Li, et al.
Veröffentlicht: (2024)